An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

This prospective open-label pilot study evaluated the effectiveness and safety of adalimumab and the relationship to antibodies against infliximab (IFX) in adult patients with active rheumatoid arthritis (RA) who had been treated previously with IFX and experienced treatment failure owing to lack or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van der Bijl, Arie E., Breedveld, Ferdinand C., Antoni, Christian E., Kalden, Joachim R., Kary, Sonja, Burmester, Gerd R., Beckmann, Christina, Unnebrink, Kristina, Kupper, Hartmut
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2008
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2468311/
https://ncbi.nlm.nih.gov/pubmed/18350329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-008-0866-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados